Norovirus Infections – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Norovirus Infections – Drugs In Development, 2024 report and make more profitable business decisions.
Noroviruses are nonenveloped, positive-sense, single-stranded RNA viruses belonging to the Caliciviridae viral family. It is a highly contagious virus causing gastroenteritis, leading to stomach and intestinal inflammation. A common cause of outbreaks of diarrhea and vomiting in schools, cruise ships, hospitals, and community gatherings, it’s nicknamed the “winter vomiting bug” due to prevalence in colder months. Symptoms encompass nausea, vomiting, diarrhea, and stomach cramps, often with fever, headache, and body aches. Spread through fecal-oral transmission, it is highly contagious, with a brief incubation of 12 to 48 hours. Prevention involves rigorous hygiene, handwashing, and surface disinfection. Outbreaks require strict measures, isolating cases, and thorough cleaning. Treatment focuses on symptom management, as there’s no specific antiviral medication or vaccine available.
The Norovirus Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Norovirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Norovirus Infections and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Norovirus Infections | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 28 molecules, with 22 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Norovirus Infections therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Norovirus Infections pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Norovirus Infections treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Blue Water Biotech IncCalici Therapeutics Inc
Cardiff University
Chengdu Kanghua Biological Products Co Ltd
Chongqing Zhifei Biological Products Co Ltd
Cincinnati Children's Hospital Medical Center
Cocrystal Pharma Inc
CyanVac LLC
German Cancer Research Center
Icon Genetics GmbH
International Vaccine Institute
iosBio Pharma Ltd
Lanzhou Institute of Biological Products Co Ltd
Lumen Bioscience Inc
Merck & Co Inc
Moderna Inc
Ostrich Pharma USA Inc
Peptineo
Prosit Sole Biotechnology (Beijing) Co Ltd
Valneva SE
Vanderbilt University
Vaxart Inc
Vernagen Inc
YuandaWeixin Life Science (Nanjing) Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Norovirus Infections reports